trihexyphenidyl has been researched along with Anochlesia in 9 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Excerpt | Relevance | Reference |
---|---|---|
"Neither catalepsy intensity nor latency were affected by a subthreshold dose of THP (0." | 1.32 | Selective A2A, but not A1 adenosine antagonists enhance the anticataleptic action of trihexyphenidyl in rats. ( Góngora-Alfaro, JL; Moo-Puc, RE; Villanueva-Toledo, J, 2003) |
" In addition, the C57BL/6 strain exhibited a greater degree of sensitization to repeated dosing than did the other 2 strains." | 1.31 | Haloperiodol-induced microcatalepsy differs in CD-1, BALB/c, and C57BL/6 mice. ( Fowler, SC; Vorontsova, E; Zarcone, TJ, 2001) |
"Histamine-induced catalepsy was antagonized potently by scopolamine, an antimuscarinic drug, and partially blocked by sparteine." | 1.28 | Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: the importance of muscarinic step in central cholinergic neurons. ( Onodera, K; Shinoda, H, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (44.44) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Voronina, TA | 1 |
Belopolskaya, MV | 1 |
Kheyfets, IA | 1 |
Dugina, JL | 1 |
Sergeeva, SA | 1 |
Epstein, OI | 1 |
Villanueva-Toledo, J | 1 |
Moo-Puc, RE | 1 |
Góngora-Alfaro, JL | 1 |
Dagaev, SG | 1 |
Fil'ko, OA | 1 |
Kubarskaya, LG | 1 |
Khrabrova, AV | 1 |
Mukovskii, LA | 1 |
Glukhova, RI | 1 |
Sanotskii, VI | 1 |
Dolgo-Saburov, VB | 1 |
Fowler, SC | 1 |
Zarcone, TJ | 1 |
Vorontsova, E | 1 |
Onodera, K | 1 |
Shinoda, H | 1 |
Andén, NE | 1 |
Bédard, P | 1 |
Kojima, M | 1 |
Nose, T | 1 |
Shintomi, K | 1 |
Yoneda, N | 1 |
Loizzo, A | 1 |
De Carolis, AS | 1 |
Longo, VG | 1 |
Morpurgo, C | 1 |
Theobald, W | 1 |
9 other studies available for trihexyphenidyl and Anochlesia
Article | Year |
---|---|
Study of bipathic effect of haloperidol.
Topics: Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Dopamine Agonists; Dose-Response Relationship | 2008 |
Selective A2A, but not A1 adenosine antagonists enhance the anticataleptic action of trihexyphenidyl in rats.
Topics: Animals; Catalepsy; Drug Synergism; Male; Muscarinic Antagonists; Purinergic P1 Receptor Antagonists | 2003 |
Effect of M2 muscarinic receptor blockade in rats with haloperidol-produced catatonic syndrome.
Topics: Animals; Catalepsy; Cyclopentanes; Diamines; Dopamine; Haloperidol; Male; Mandelic Acids; Muscarinic | 2004 |
Haloperiodol-induced microcatalepsy differs in CD-1, BALB/c, and C57BL/6 mice.
Topics: Animals; Antipsychotic Agents; Catalepsy; Conditioning, Operant; Dose-Response Relationship, Drug; H | 2001 |
Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: the importance of muscarinic step in central cholinergic neurons.
Topics: Amantadine; Animals; Atropine; Biperiden; Bromocriptine; Catalepsy; Histamine; Injections, Intravent | 1991 |
Influences of cholinergic mechanisms on the function and turnover of brain dopamine.
Topics: Animals; Apomorphine; Atropine; Basal Ganglia; Brain; Catalepsy; Cyclopentanes; Dopamine; Hallucinog | 1971 |
Pharmacology of a new anti-parkinsonian drug: KAO-264.
Topics: Animals; Atropine; Catalepsy; Haloperidol; Haplorhini; Humans; Mydriatics; Parasympatholytics; Thiop | 1971 |
Studies on the central effects of bulbocapnine.
Topics: 5-Hydroxytryptophan; Animals; Aporphines; Catalepsy; Cats; Cerebral Cortex; Dihydroxyphenylalanine; | 1971 |
Influence of antiparkinson drugs and amphetamine on some pharmacological effects of phenothiazine derivatives used as neuroleptics.
Topics: Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Body Temperature; Catalepsy | 1964 |